Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US.

Villalobos VM, Byfield SD, Ghate SR, Adejoro O.

Clin Sarcoma Res. 2017 Nov 9;7:18. doi: 10.1186/s13569-017-0084-4. eCollection 2017.

2.

Clinical and economic outcomes by first-line treatment among women with HR+/HER2- metastatic breast cancer in a large US health plan database.

Burton T, Byfield SD, Smith GL, Zanotti G, Bell TJ, Perkins JJ, Horblyuk R, Teitelbaum A.

Curr Med Res Opin. 2016 Aug;32(8):1417-23. doi: 10.1080/03007995.2016.1178108. Epub 2016 May 12.

PMID:
27074160
3.

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.

Levy DE, Byfield SD, Comstock CB, Garber JE, Syngal S, Crown WH, Shields AE.

Genet Med. 2011 Apr;13(4):349-55. doi: 10.1097/GIM.0b013e3182091ba4.

4.

Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.

Jonasch E, Lal LS, Atkinson BJ, Byfield SD, Miller LA, Pagliaro LC, Feng C, Tannir NM.

BJU Int. 2011 Mar;107(5):741-747. doi: 10.1111/j.1464-410X.2010.09626.x. Epub 2010 Sep 21.

5.

Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases.

Lal LS, Byfield SD, Chang EL, Franzini L, Miller LA, Arbuckle R, Reasonda L, Feng C, Adamus A, Swint JM.

Am J Clin Oncol. 2012 Feb;35(1):45-50. doi: 10.1097/COC.0b013e3182005a8f.

PMID:
21293245
6.

Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.

Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC.

Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):19-27. Epub 2005 Nov 11. Review.

PMID:
16290023
7.

Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.

Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE, Roberts AB.

Cancer Res. 2004 Jul 1;64(13):4523-30.

8.

Lateral signaling enhances TGF-beta response complexity.

Byfield SD, Roberts AB.

Trends Cell Biol. 2004 Mar;14(3):107-11. Review.

PMID:
15055198

Supplemental Content

Loading ...
Support Center